Literature DB >> 19355963

Synthetic and natural immunomodulators acting as interferon inducers.

Dmytro S Silin1, Oksana V Lyubomska, Feliks I Ershov, Valeriy M Frolov, Galyna A Kutsyna.   

Abstract

Interferons are first immunomodulatory molecules that have been shown to display a wide range of applications due to their antiviral, antibacterial, antitumor, and inflammatory activities. Natural and recombinant interferons are among most common biologic therapeutics worldwide. Interferon inducers, however, are less known and have been mostly developed and used in former socialist countries. Despite the fact that they are virtually unknown to the Western world, they represent a substantial market share of modern pharmacopoeia in former socialist republics. This review provides a brief description of most popular interferon inducers including Amyxin, Amizon, Anandin, Arbidol, Blasten, Cycloferon, Galavit, Groprinosine, Hepon, Immunoxel, Dzherelo, Kagocel, Larifan, Ligfol, Likopid, Mebavin, MIGI-KLP, V-5 Immunitor, SCV-07, Milife, Neovir, Poludan, Ragocin, Ridostin, Thymogen and Savratz, some of which were in use for several decades for the same clinical indications as for interferons. The variety and choice offered by the pharmaceutical industry behind the former "iron curtain" certainly deserves the appreciation, familiarity and application prospects for medical and research investigators worldwide.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19355963     DOI: 10.2174/138161209787846847

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  11 in total

1.  Exogenous interferon prolongs survival of rabies infected mice.

Authors:  S Mehta; S Roy; S Mukherjee; N Yadav; N Patel; A Chowdhary
Journal:  Virusdisease       Date:  2015-08-14

2.  Tilorone and Cridanimod Protect Mice and Show Antiviral Activity in Rats despite Absence of the Interferon-Inducing Effect in Rats.

Authors:  Viktoriya Keyer; Laura Syzdykova; Gulzat Zauatbayeva; Aigerim Zhulikeyeva; Yerlan Ramanculov; Alexandr V Shustov; Zarina Shulgau
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-17

3.  Antiviral and anti-inflammatory activity of arbidol hydrochloride in influenza A (H1N1) virus infection.

Authors:  Qiang Liu; Hai-rong Xiong; Li Lu; Yuan-yuan Liu; Fan Luo; Wei Hou; Zhan-qiu Yang
Journal:  Acta Pharmacol Sin       Date:  2013-06-17       Impact factor: 6.150

4.  Species-specific detection of the antiviral small-molecule compound CMA by STING.

Authors:  Taner Cavlar; Tobias Deimling; Andrea Ablasser; Karl-Peter Hopfner; Veit Hornung
Journal:  EMBO J       Date:  2013-04-19       Impact factor: 11.598

5.  Do we need a replacement medication for influenza with good efficacy?

Authors:  Mahmoud Arastoo; Hamid Reza Khorram Khorshid
Journal:  Daru       Date:  2014-12-16       Impact factor: 3.117

6.  Results of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage II-IV breast cancer.

Authors:  Anastasia S Proskurina; Tatiana S Gvozdeva; Ekaterina A Alyamkina; Evgenia V Dolgova; Konstantin E Orishchenko; Valeriy P Nikolin; Nelly A Popova; Sergey V Sidorov; Elena R Chernykh; Alexandr A Ostanin; Olga Y Leplina; Victoria V Dvornichenko; Dmitriy M Ponomarenko; Galina S Soldatova; Nikolay A Varaksin; Tatiana G Ryabicheva; Peter N Uchakin; Stanislav N Zagrebelniy; Vladimir A Rogachev; Sergey S Bogachev; Mikhail A Shurdov
Journal:  BMC Cancer       Date:  2015-03-13       Impact factor: 4.430

7.  TRAIN (Transcription of Repeats Activates INterferon) in response to chromatin destabilization induced by small molecules in mammalian cells.

Authors:  Katerina Leonova; Alfiya Safina; Elimelech Nesher; Poorva Sandlesh; Rachel Pratt; Catherine Burkhart; Brittany Lipchick; Ilya Gitlin; Costakis Frangou; Igor Koman; Jianmin Wang; Kirill Kirsanov; Marianna G Yakubovskaya; Andrei V Gudkov; Katerina Gurova
Journal:  Elife       Date:  2018-02-05       Impact factor: 8.140

8.  Characterization of a Novel Human-Specific STING Agonist that Elicits Antiviral Activity Against Emerging Alphaviruses.

Authors:  Tina M Sali; Kara M Pryke; Jinu Abraham; Andrew Liu; Iris Archer; Rebecca Broeckel; Julia A Staverosky; Jessica L Smith; Ahmed Al-Shammari; Lisi Amsler; Kayla Sheridan; Aaron Nilsen; Daniel N Streblow; Victor R DeFilippis
Journal:  PLoS Pathog       Date:  2015-12-08       Impact factor: 6.823

Review 9.  Advances in rabies prophylaxis and treatment with emphasis on immunoresponse mechanisms.

Authors:  A El-Sayed
Journal:  Int J Vet Sci Med       Date:  2018-05-18

10.  Regioselective synthesis of 6-substituted-2-amino-5-bromo-4(3H)-pyrimidinones and evaluation of their antiviral activity.

Authors:  Kamaljit Singh; Kawaljit Singh; Jan Balzarini
Journal:  Eur J Med Chem       Date:  2013-07-05       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.